Skip to content

To compare the analgesic efficacy of local anesthetic bupivacaine when combined with fentanyl or dexmeditomidine in laproscopic cholecystectomy

Comparison of analgesic efficacy of intraperitoneal bupivacaine with dexmedetomidine or fentanyl as adjuvants, in patients undergoing ambulatory laparoscopic cholecystectomy

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/07/020466
Enrollment
90
Registered
2019-07-31
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K819- Cholecystitis, unspecified Health Condition 2: null- Symptomatic Cholecystitis and Cholelithiasis posted for Laparoscopic Cholecystectomy

Interventions

Intervention1: Intraperitoneal bupivacaine alone vs intraperitoneal bupivavaine with demedetomidine or fentanyl: According to the random number, the patient will be allocated to one of the three group

Sponsors

Dr Sudarshan Kumar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA physical status I and II, who have to undergo ambulatory laparoscopic cholecystectomy for symptomatic cholecystitis and cholelithiasis

Exclusion criteria

Exclusion criteria: 1. BMI less than 18 or > 30 2. Patients who are converted into open cholecystectomy 3. Patients who have bleeding liver bed 4. Psychiatric patient 5. Patients who have coagulation disorder 6. Patients who have allergy to local anaesthetics, dexmedetomidine or fentanyl 7. Patients in whom the drains are to be kept postoperatively. 8. Patients of heart block or those having heart rate less than 50.

Design outcomes

Primary

MeasureTime frame
To assess the recovery profile of patients undergoing ambulatory laparoscopic cholecystectomyTimepoint: The time 0 starts when patient is shifted to PACU, 1, 2, 4, 6 hours interval after surgery

Secondary

MeasureTime frame
To assess postoperative analgesia, requirement of rescue analgesia, haemodynamic stability and other side effectsTimepoint: The time 0 starts when patient is shifted to PACU, 1, 2, 4, 6 hours interval after surgery

Countries

India

Contacts

Public ContactRipudaman Singh

Dr Rajendra Prasad Government Medical College

drbharti203@gmail.com9418044928

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 14, 2026